Particle radiosurgery: A new frontier of physics in medicine

Physica Medica

Volumn 30, Issue 5, 2014, Pages 535-538

  Bert, Christoph ^a,b   Durante, Marco ^b,c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GSI HELMHOLTZZENTRUM FÜR SCHWERIONENFORSCHUNG GMBH   (Germany)

^c DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Hypofractionation; Particle beam therapy; Radiation therapy

Indexed keywords

ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN DAMAGE; EXTRACRANIAL LESION; FRACTIONATION; HEART ATRIUM FIBRILLATION; HUMAN; HYPOPHYSIS ADENOMA; IMMOBILIZATION; ION THERAPY; NONHUMAN; PATIENT POSITIONING; POSITRON EMISSION TOMOGRAPHY; PROTON RADIOGRAPHY; RADIATION DOSE; RADIOBIOLOGY; RADIOGRAPHY; RADIOTHERAPY; REAL TIME TUMOR TRACKING RADIOTHERAPY; RETINA MACULA AGE RELATED DEGENERATION; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; TRIGEMINUS NEURALGIA; DIAGNOSTIC USE; MEDICINE; PHYSICAL PHENOMENA; RADIOSURGERY;

PROTON;

HUMANS; MEDICINE; PHYSICAL PROCESSES; PROTONS; RADIOBIOLOGY; RADIOGRAPHY; RADIOSURGERY;

EID: 84902270018     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2014.04.011     Document Type: Article

References (47)

1. Leksell L. The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 1951, 102:316-319.
2. Loeffler J.S., Durante M. Charged particle therapy-optimization, challenges and future directions. Nat Rev Clin Oncol 2013, 10:411-424.
3. Bert C., Engenhart-Cabillic R., Durante M. Particle therapy for noncancer diseases. Med Phys 2012, 39:1716-1727.
4. Williams T.M., Maier A. Role of stereotactic body radiation therapy and proton/carbon nuclei therapies. Cancer J 2013, 19:272-281.
5. Tsujii H., Kamada T. Areview of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol 2012, 42:670-685.
6. Tsujii H., Kamada T., Shirai T., Noda K., Tsuji H., Karasawa K. Carbon-ion radiotherapy 2014, Springer, Tokyo. 1st ed.
7. Kjellberg R.N., Hanamura T., Davis K.R., Lyons S.L., Adams R.D. Bragg-peak proton-beam therapy for arteriovenous-malformations of the brain. New Engl J Med 1983, 309:269-274.
8. Lettmaier S. Radiosurgery in trigeminal neuralgia. Phys Medica 2014, 30:592-595.
9. Kishan A.U., Modjtahedi B.S., Morse L.S., Lee P. Radiation therapy for neovascular age-related macular degeneration. Int J Radiat Oncol Biol Phys 2013, 85:583-597.
10. Park S.S., Daftari I., Phillips T., Morse L.S. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration. Retina-J Ret Vit Dis 2012, 32:956-966.
11. Sharma A., Wong D., Weidlich G., Fogarty T., Jack A., Sumanaweera T., et al. Noninvasive stereotactic radiosurgery (cyberheart) for creation of ablation lesions in the atrium. Heart Rhythm 2010, 7:802-810.
12. Constantinescu A., Lehmann H.I., Graeff C., Packer D., Durante M., Bert C. Planning studies for non-invasive isolation of the pulmonary veins with a scanned carbon ion beam. Heart Rhythm 2013, 10:S33.
13. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300:1155-1159.
14. Fuks Z., Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell 2005, 8:89-91.
15. Greco C., Zelefsky M.J., Lovelock M., Fuks Z., Hunt M., Rosenzweig K., et al. Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. Int J Radiat Oncol Biol Phys 2011, 79:1151-1157.
16. Brown J.M., Carlson D.J., Brenner D.J. The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?. Int J Radiat Oncol Biol Phys 2014, 88:254-262.
17. Friedrich T., Scholz U., Durante M., Scholz M. RBE of ion beams in hypofractionated radiotherapy (SBRT). Phys Medica 2014, 30:588-591.
18. Lambin P., van Stiphout R., Starmans M.H.W., Rios-Velazquez E., Nalbantov G., Aerts H., et al. Predicting outcomes in radiation oncology-multifactorial decision support systems. Nat Rev Clin Oncol 2013, 10:27-40.
19. Aerts H., Bussink J., Oyen W.J.G., van Elmpt W., Folgering A.M., Emans D., et al. Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. Lung Cancer 2012, 75:73-76.
20. Aerts H., van Baardwijk A.A.W., Petit S.F., Offermann C., van Loon J., Houben R., et al. Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan. Radiother Oncol 2009, 91:386-392.
21. Schneider U., Pedroni E. Proton radiography as a tool for quality control in proton therapy. Med Phys 1995, 22:353-363.
22. Steward V.W., Koehler A.M. Proton radiographic detection of strokes. Nature 1973, 245:38-40.
23. Koehler A.M. Proton radiography. Science 1968, 160:303-304.
24. Testa M., Verburg J.M., Rose M., Min C.H., Tang S.K., Bentefour E., et al. Proton radiography and proton computed tomography based on time-resolved dose measurements. Phys Med Biol 2013, 58:8215-8233.
25. Schulte R.W., Bashkirov V., Klock M.C.L., Li T.F., Wroe A.J., Evseev I., et al. Density resolution of proton computed tomography. Med Phys 2005, 32:1035-1046.
26. Petit S., Seco J., Kooy H. Increasing maximum tumor dose to manage range uncertainties in IMPT treatment planning. Phys Med Biol 2013, 58:7329-7341.
27. Parodi K. Heavy ion radiography and tomography. Phys Medica 2014, 30:539-543.
28. Rinaldi I., Brons S., Gordon J., Panse R., Voss B., Jakel O., et al. Experimental characterization of a prototype detector system for carbon ion radiography and tomography. Phys Med Biol 2013, 58:413-427.
29. Enghardt W., Debus J., Haberer T., Hasch B.G., Hinz R., J"kel O., et al. The application of PET to quality assurance of heavy-ion tumor therapy. Strahlenther Onkol 1999, 175(Suppl.2):33-36.
30. Parodi K., Paganetti H., Shih H.A., Bonab A.A., Cascio E.W., Michaud S., et al. PET/CT image guidance for treatment verification after proton therapy: an experimental study. Strahlenther Onkol 2006, 182:137.
31. Parodi K., Paganetti H., Shih H.A., Michaud S., Loeffler J.S., DeLaney T.F., et al. Patient study of invivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy. Int J Radiat Oncol Biol Phys 2007, 68:920-934.
32. Kraan A.C., Battistoni G., Belcari N., Camarlinghi N., Cirrone G.A.P., Cuttone G., et al. Proton range monitoring with in-beam pet: Monte carlo activity predictions and comparison with cyclotron data. Phys Medica 2014, 30:559-569.
33. Varentsov D., Bogdanov A., Demidov V.S., Golubev A.A., Kantsyrev A., Lang P.M., et al. First biological images with high-energy proton microscopy. Phys Medica 2013, 29:208-213.
34. Chapman P.H., Ogilvy C.S., Butler W.E. Anew stereotactic alignment system for charged-particle radiosurgery at the Harvard Cyclotron Laboratory, Boston. Stereotactic radiosurgery 1993, 105-108. McGraw-Hill, New York. E.I. Alexander, J.S. Loeffler, L.D. Lunsford (Eds.).
35. Korreman S.S. Motion in radiotherapy: photon therapy. Phys Med Biol 2012, 57:R161-R191.
36. Bert C., Durante M. Motion in radiotherapy: particle therapy. Phys Med Biol 2011, 56:R113-R114.
37. Knopf A.-C., Lomax A.J. In the context of radiosurgery - pros and cons of rescanning as a solution for treating moving targets with scanned particle beams. Phys Medica 2014, 30:551-554.
38. Minohara S., Kanai T., Endo M., Noda K., Kanazawa M. Respiratory gated irradiation system for heavy-ion radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47:1097-1103.
39. Habermehl D., Debus J., Ganten T., Ganten M.K., Bauer J., Brecht I.C., et al. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response. Radiat Oncol 2013, 8:59.
40. Richter D., Saito N., Chaudhri N., Härtig M., Ellerbrock M., Jäkel O., et al. 4D patient dose reconstruction for scanned ion beam therapy of moving liver tumors. Int J Radiat Oncol Biol Phys 2013, 89:175-181.
41. Shirato H., Oita M., Fujita K., Watanabe Y., Miyasaka K. Feasibility of synchronization of real-time tumor-tracking radiotherapy and intensity-modulated radiotherapy from viewpoint of excessive dose from fluoroscopy. Int J Radiat Oncol Biol Phys 2004, 60:335-341.
42. Shimizu S., Matsuura T., Umezawa M., Hiramoto K., Miyamoto N., Umegaki K., et al. Preliminary analysis for integration of spot-scanning proton beam therapy and real-time imaging and gating. Phys Medica 2014, 30:555-558.
43. Schwaab J., Prall M., Sarti C., Kaderka R., Bert C., Kurz C., et al. Ultrasound tracking for intra-fractional motion compensation in radiation therapy. Phys Medica 2014, 30:578-582.
44. Graeff C., Luchtenborg R., Eley J.G., Durante M., Bert C.A. 4D-optimization concept for scanned ion beam therapy. Radiother Oncol 2013, 109:419-424.
45. Graeff C. Motion mitigation in scanned ion beam therapy through 4D-optimization. Phys Medica 2014, 30:570-577.
46. Kamp F., Brueningk S., Cabal G., Mairani A., Parodi K., Wilkens J.J. Variance-based sensitivity analysis of biological uncertainties in carbon ion therapy. Phys Medica 2014, 30:583-587.
47. Dosanjh M., Cirilli M., Navin S. Enlight and leir biomedical facility. Phys Medica 2014, 30:544-550.